JT and Torii conclude agreement to market novel anti-HIV ...

Aug 28, 2012 · “JT and Torii conclude agreement to market novel anti-HIV single-tablet regimen containing JTK-303 (elvitegravir) in Japan” (a press release by JT and Torii dated August 28, 2012.) ### Japan Tobacco Inc. is a leading international tobacco product company. Its products are sold in over 120 ................
................